搜索
搜索
Your location:
Homepage
/
/
/
95% of medicine packaging cannot prevent children from taking it by mistake

95% of medicine packaging cannot prevent children from taking it by mistake

(Summary description) Pharmaceutical child safety packaging refers to certain varieties of medicines for children and adults (such as cardiovascular and cerebrovascular treatment drugs

95% of medicine packaging cannot prevent children from taking it by mistake

(Summary description) Pharmaceutical child safety packaging refers to certain varieties of medicines for children and adults (such as cardiovascular and cerebrovascular treatment drugs

Information

  Pharmaceutical child safety packaging refers to certain varieties of medicines for children and adults (such as cardiovascular and cerebrovascular treatment drugs, hypertension treatment drugs, mental drugs, etc.), using a packaging form that is not easy for children to open or tear. Prevent children from taking it by mistake and avoid causing injury. Statistics from the China Medical Packaging Association show that more than 95% of the drugs in my country's drug market do not have the function of packaging children's drugs, and my country has not yet established independent standards and regulations for children's safe packaging.

img

At the Fifth “Voice· Responsibility” Symposium of Representatives of the National People’s Congress and CPPCC Committee Members of the Pharmaceutical Industry in 2013 jointly organized by 24 Chinese pharmaceutical industry associations (learning) such as China Pharmaceutical Enterprise Management Association, China Pharmaceutical Packaging Association It is proposed that legislation on the safe packaging of medicines for children should be introduced.

The association revealed that almost 95% of the drugs in the current drug market in my country do not have the function of children's drug packaging, and their safety tips are generally only reflected in simple text descriptions; in the safety design of the bottle mouth, there are only very few Health care drugs (such as vitamins, shark essence, etc.) and children's cough medicine products are available; blister-packed tablets and capsules do not have safe packaging. Some imported drug manufacturers also ignore the child safety packaging of drugs in order to reduce production costs.

Every year 30,000 to 50,000 children seek medical treatment due to drug poisoning

According to the existing domestic research data collected by the China Medical Packaging Association in 2011 and the data collected from hospitals in Beijing and Shanghai, it is roughly estimated that the number of children (under 15 years of age) who seek medical attention for drug poisoning in my country is about 3 to 50,000, which does not include the number of people who were poisoned but did not go to the hospital.

From the point of view of pharmacology and toxicology, because children's body development is immature, the metabolism of drugs in the body has its particularity and complexity, which makes some drugs unsuitable for children. However, the color, shape and sweet icing of some medicines is a great temptation for the ignorant children. Children who are curious and ignorant, open the medicine or poisonous substance package by themselves, and they will cause certain harm. May leave sequelae.

According to some data, it is estimated that about 2,000 to 3,000 children die each year due to drug poisoning, and there are about 3,000 to 4,000 children who have sequelae or become disabled due to drug poisoning. The annual cost of treating and treating these patients is about 200 million to 300 million.

40% of children have stolen drugs

img

According to data, after a doctor surveyed several parents of children aged 1-3, they found that 40% of the children had stolen drugs. In order to prevent children from opening safe drug packaging, European and American countries attach great importance to it. According to the World Health Organization and foreign documents, this issue was noticed in the 1970s. In 1974, legislation forced all oral drugs to adopt safe packaging that prevents children from opening. It has been implemented for twenty years.

The World Health Organization pointed out in the "Child and Adolescent Injury Prevention, World Health Organization (WHO) Action Plan 2006-2015" report that laws and other forms of regulations have proven to be one of the more powerful mechanisms for injury prevention. According to the World Health Organization and foreign documents, in countries where manufacturers of drugs and toxic substances are mandatory to provide child-resistant packaging, the number of children seeking medical care due to drug poisoning has dropped significantly.

According to the data of my country's sixth national census released at the end of April 2011, my country's population of 0-14 years old is 220 million, accounting for approximately 16.6% of the country's total population. According to the statistics of the All-China Women’s Federation in 2011, the number of left-behind children in the country is about 58 million, most of which are concentrated in the central and western provinces with large populations. Among them, there are more than 40 million left-behind children under the age of 14 and left-behind children account for 28.29% of all rural children, and more than 80%. The left-behind children are under the inter-generational supervision of grandparents and temporary supervision of relatives and friends. The guardianship responsibility is not fulfilled and the awareness of prevention is lacking, and left-behind children in rural areas are more likely to suffer accidental injuries.

According to the China Pharmaceutical Packaging Association, some parents now have certain preventive measures, such as putting medicines out of the children's reach, taking medicines improperly in front of their children to prevent imitation, etc., but these measures are not enough. Child-safe packaging of medicines is the fundamental way to reduce accidental swallowing of medicines by children.

"my country's medicines should adopt a legislative method, and it is mandatory to require medicine packaging to have a child protection function, which reflects the country's attention and protection of children's rights and interests. ”

img

According to the “Survey on Legislation Recommendations for Child Safety Packaging of Medicines” conducted by the State Food and Drug Administration in 2012, the technology and industry for the production and use of child safety protection devices in my country have been very mature, except for some European and American child safety packaging manufacturers that have established Many local companies in China already have the production capacity for child-safe packaging.

Therefore, the China Medical Packaging Association recommends that government departments should take the lead in launching the legislation for the safe packaging of medicines for children in my country as soon as possible, and introduce relevant supporting policies and measures to minimize the incidence of accidental ingestion of medicines by children in my country.

img

Keyword:

Scan the QR code to read on your phone

Real-time News

img
Yangzhou Jerel Pharmaceutical New Materials Co., Ltd. (hereinafter referred to as "Jerel") will participate in the Pharmaconex Pharmaceutical Exhibition held at the Cairo International Exhibition Center in Egypt from September 8 to 10, 2024. As a leading global supplier of pharmaceutical packaging materials, JEREL will showcase its latest products and technologies at this exhibition to provide high-quality pharmaceutical packaging solutions for customers around the world.
In the pharmaceutical industry chain, pharmaceutical packaging material companies are often regarded as "behind-the-scenes heroes", but whether they should be classified as pharmaceutical companies has sparked widespread discussion. Pharmaceutical packaging materials play a vital role in ensuring the safety, effectiveness and quality of drugs. Therefore, more and more voices believe that these companies should be included in the category of pharmaceutical companies.
As consumers pay more and more attention to health and safety, packaging materials for drugs and foods have become the focus of public attention. However, although there are similarities between drug and food packaging materials in some aspects, the differences between them are crucial, especially in material selection, performance requirements and regulatory standards.
In the pharmaceutical industry, pharmaceutical packaging materials serve as important barriers to protect drug quality and ensure patient safety. The quality and performance of these materials directly affect the stability and effectiveness of drugs. With the continuous advancement of medical technology and increasing demands for drug safety from patients, stricter and more comprehensive requirements have been proposed for the inspection standards of pharmaceutical packaging materials. Pharmaceutical aluminum foil, as a high-quality material widely used in drug packaging, plays an irreplaceable role in ensuring drug quality due to its unique barrier properties, corrosion resistance, and heat-sealing performance. This article aims to explore the inspection standards of pharmaceutical packaging materials, using pharmaceutical aluminum foil as an example, and elaborates on specific requirements in terms of physical properties, microbial contamination, heat-sealing performance, and others.
With the advancement of technology and the diversification of consumer demands, the markets for dietary supplements and pharmaceuticals are flourishing. Their packaging serves as the "first impression" of the products, carrying not only the basic functions of protecting and facilitating portability but also serving as a crucial medium for conveying product information, shaping brand image, and safeguarding consumer rights. Starting from the nature of dietary supplements and pharmaceuticals, we can delve deeper into analyzing the differences in their packaging.
Medications are essential in our daily lives, and their quality and safety often depend on the packaging materials used. Pharmaceutical cold aluminum foil, a new type of drug packaging material, offers unique advantages for efficiently storing medications, making it an ideal choice for long-term preservation. Traditional drug packaging materials, such as plastic bottles, typically only meet basic packaging needs and pose several issues regarding drug safety and shelf life. The advent of pharmaceutical cold aluminum foil provides a new solution in the pharmaceutical packaging field, leading to widespread application. The advantages of pharmaceutical cold aluminum foil are mainly reflected in the following four aspects.
PVC (Polyvinyl Chloride) is a synthetic plastic made from vinyl chloride monomers through polymerization reactions. It is the third largest synthetic polymer plastic in the world (after polyethylene and polypropylene) and can be traced back to the late 19th and early 20th centuries. PVC gradually became an important material in various fields. Among them, medicinal PVC hard sheets are a common pharmaceutical packaging material, with good sealing, moisture resistance, and corrosion resistance.
The importance of pharmaceutical packaging materials in the pharmaceutical packaging market is undeniable. Pharmaceutical packaging plays a crucial role in ensuring the safety, efficacy, and quality of pharmaceutical products. The packaging market in the pharmaceutical industry is continuously evolving to meet the changing needs and regulations.
The pharmaceutical packaging materials play a crucial role in ensuring the quality and safety of drugs, among which pharmaceutical aluminum foil, as a widely used packaging material, has numerous remarkable characteristics and advantages. It possesses good moisture resistance, airtightness, and sealability.
In the field of medicine, blister packs are a common form of drug packaging. However, have you noticed that some blister packs have an additional protective layer? This protective layer is usually made of tropical aluminum, and its presence is not accidental but holds significant importance and value.
The content of the standards for pharmaceutical packaging materials products is to ensure that the packaging materials meet a series of regulations and requirements for pharmaceutical packaging needs. These standards aim to safeguard the safety, stability, effectiveness, and compliance of pharmaceutical packaging materials, ensuring that drugs are not contaminated or deteriorated during transportation, storage, and use. The specific content of the standards for pharmaceutical packaging materials products includes:
Cold forming and thermoforming are not just different in terms of temperature. In the blister packaging manufacturing process, they are two common production methods with significant differences in processes, material selection, product performance, and application areas.

Online Message

Ask about our products and prices, please leave your email, and we will contact you within 24 hours.

QR code scanning
Sweep, mobile station

Sweep, mobile station

Electronic business card

Electronic business card

Telephone

Address

Daqiao Industrial Park, Jiangdu, Yangzhou,China

Copyright:Yangzhou Jerel Pharmaceutical New Material Co., Ltd.  Powered by www.300.cn   苏ICP备13054439号-1